Global Emerging Diseases Institute: Medical Leadership | Tampa General Hospital

Global Emerging Diseases Institute: Medical Leadership

John Sinnott, MD

John Sinnott, MD

Chief, TGH Global Emerging Diseases Institute

Dr. John Sinnott serves as Chief of Tampa General's Global Emerging Diseases Institute. Sinnott graduated from Columbus College in Georgia and received a Master of Science degree from the University of South Florida in microbiology. He was awarded an MD degree from University of South Alabama. Sinnott completed his postdoctoral training at the University of South Florida. He completed an internal medicine residency and infectious diseases and tropical medicine fellowship at the University of South FloridaWhile director of the Infectious Disease, Dr. Sinnott started the USF Florida Institute for Infectious Disease which helped the state spearhead a biodefense education program while building a nationally recognized infectious disease fellowship. In 2001, he was appointed as the Senior Advisor for Biodefense to Florida Secretary of Health Dr. John Agwunobi. In 2006, Sinnott served on Governor Charlie Crist's Transition Team, advising on health care. In 2020, Dr. Sinnott was invited to serve as a consultant at the World Economic Forum. In 2021, Sinnott was a research physician on the team that created a novel, patented 3D-printed swab for COVID-19 diagnosis. The team, led by Summer Decker PhD, successfully conducted a multi-site national clinical trial at Tampa General Hospital within a span of two weeks, a process that typically takes years, and produced swabs that cost approximately $0.25 each to produce. 


Kami Kim, MD

Director of Research, TGH Global Emerging Diseases Institute

Dr. Kami Kim serves as director of research at Tampa General Hospital’s Global Emerging Diseases Institute. Dr. Kim is an NIH-funded investigator who leads infectious diseases clinical research efforts at TGH. She served as site principal investigator of COVID-19 clinical trials for 3D swabs, antiviral treatments, monoclonal antibodies, and COVID-19 vaccines. Dr. Kim works closely with the TGH Esoteric laboratory led by Dr. Suzane Silbert to track the emergence of SARS-CoV2 variants. She is also working with the TGH business intelligence group and TGH clinical teams to use big data and artificial intelligence to improve infectious diseases clinical outcomes. Dr. Kim completed her training in internal medicine at Columbia Presbyterian Medical Center (now New York Presbyterian Hospital), infectious diseases training at University of California-San Francisco, and post-doctoral research training at Stanford University School of Medicine. She is a member of the editorial advisory board of the Sanford Guide for Antimicrobial Therapy.